HOME >> BIOLOGY >> NEWS
GroPep infertility data presented at US meeting

crinology have arisen by the discovery and clinical application of defined hormones. These data demonstrate the very real possibility of pharmacotherapy for recurrent miscarriage using a defined agent. Now clinical reproductive immunology may be able to move forward."

GroPep is currently undertaking additional pre-clinical work in preparation for a Phase 1 clinical trial. Studies aimed at optimising the PV903 formulation as well as defining clinical endpoints will underpin the clinical program planned to commence in Adelaide in 2006.

GroPep advised on December 20, 2004 that it intends to proceed with the PV903 project towards a Phase 1 clinical trial. This latest data confirms that position.


'"/>

Contact: Mr Tony Mitchell
investorrelations@gropep.com.au
61-8-8354-7700
Research Australia
13-Jun-2005


Page: 1 2

Related biology news :

1. GroPep announces US FDA approval of biopharmaceutical that uses its cell culture product
2. GroPep announces Japanese approval of biopharmaceutical that uses its cell culture products
3. Male or female factor infertility -- men suffer just the same
4. Risk-taking in infertility treatment correlates with womens negative moods
5. New research holds promise for protecting cancer patients against infertility
6. Stressed-out African naked mole-rats may provide clues about human infertility
7. Key to male infertility
8. Researchers find gene mutation that causes infertility in male mice
9. Treating male infertility with stem cells
10. Eating ice cream may help women to conceive, but low-fat dairy foods may increase infertility risk
11. World-first stem cell research could aid male infertility

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the first in ... on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor ... live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition ...
(Date:7/2/2020)... Calif. (PRWEB) , ... July 01, 2020 , ... ... company, presented its phase 1a findings of Neihulizumab, a biologic for the treatment ... in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred ...
(Date:7/1/2020)... ... 2020 , ... Catalent, a global leader in clinical supply ... facility in Minakuchi, located in the Shiga prefecture of Japan. , Operating in ... new 60,000-square-foot facility will provide customers with flexible clinical supply solutions, serving both ...
Breaking Biology News(10 mins):
(Date:6/11/2020)... ... June 09, 2020 , ... PathSensors Inc., a ... Business Innovation Research (SBIR) program funded by the National Institute of Food and ... the Field”. The project’s goal was to engineer and develop a field-deployable instrument ...
(Date:6/2/2020)... ... June 01, 2020 , ... ... and encourage positive change in the world, enterprise security solutions provider bitsIO donated ... more people working from home during self-quarantines and shelter-in-place orders, companies are increasingly ...
(Date:5/28/2020)... ... , ... The Security Industry Association (SIA) and SecureIDNews ... Women in Biometrics Awards – a globally recognized program co-founded by SIA ... the SIA Women in Security Forum . The honorees will be recognized during ...
(Date:5/21/2020)... BALTIMORE (PRWEB) , ... May 19, 2020 , ... Eaton ... with the addition of Popper and Company, a biotechnology and medical technology-focused strategy and ... continues to grow in the United States, linking US and Asia Pacific healthcare innovators ...
Breaking Biology Technology:
Cached News: